Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.
Low-barrier care and access to multiple services in one place can improve outcomes for people experiencing homelessness or unstable housing.
The Epclusa and Mavyret combination pills are now indicated for kids as young as age 3.
Assessing patient-reported outcomes can support treatment for hard-to-reach populations.
His reason: The settlement granting inmates hepatitis C treatment also prevents them from suing the state for any reason.
About 2.4 million Americans are living with hepatitis C and 862,000 have hep B. Spread the word about this hidden epidemic.
Based on surveys conducted in 2015 and 2018, the number appears to have nearly tripled in San Francisco.
Among people treated for hepatitis C, diabetes and chronic kidney disease were both linked to a higher risk of cardiovascular death.
This means that Tennessee can ration hepatitis C treatment among prisoners living with the life-threatening virus.
This guide explains key aspects of today’s most effective hep C therapies
“We’re going to see a surge in cases,” TAG’s Annette Gaudino tells WCNY about New York’s hepatitis C efforts. “We have fallen behi...
After inmates filed a class action lawsuit, Nevada agreed to treat all prisoners living with hepatitis C.
The risk was lower in people who had achieved a sustained virological response compared with those who had not.
Despite limited testing and clinical visits, 95% of the study population was able to achieve a sustained virological response.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
Premature discontinuation of hepatitis C treatment did not diminish the likelihood of sustained virological response.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.